GR3036047T3 - Inherited and somatic mutations of apc gene in colorectal cancer of humans. - Google Patents

Inherited and somatic mutations of apc gene in colorectal cancer of humans.

Info

Publication number
GR3036047T3
GR3036047T3 GR20010400861T GR20010400861T GR3036047T3 GR 3036047 T3 GR3036047 T3 GR 3036047T3 GR 20010400861 T GR20010400861 T GR 20010400861T GR 20010400861 T GR20010400861 T GR 20010400861T GR 3036047 T3 GR3036047 T3 GR 3036047T3
Authority
GR
Greece
Prior art keywords
apc
colorectal cancer
inherited
humans
somatic mutations
Prior art date
Application number
GR20010400861T
Other languages
English (en)
Inventor
Kenneth W Kinzler
Bert Vogelstein
Rakesh Anand
Philip John Hedge
Alexander Fred Markham
Hans Albertsen
Mary L Carlson
Joanna L Groden
Geoff Joslyn
Andrew Thliveris
Raymond L White
Yusuke Nakamura
Original Assignee
Univ Johns Hopkins
Ici Plc
Univ Utah
Japan Found Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919100963A external-priority patent/GB9100963D0/en
Priority claimed from US07/741,940 external-priority patent/US5352775A/en
Application filed by Univ Johns Hopkins, Ici Plc, Univ Utah, Japan Found Cancer filed Critical Univ Johns Hopkins
Publication of GR3036047T3 publication Critical patent/GR3036047T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GR20010400861T 1991-01-16 2001-06-14 Inherited and somatic mutations of apc gene in colorectal cancer of humans. GR3036047T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919100963A GB9100963D0 (en) 1991-01-16 1991-01-16 Nucleic acid
US07/741,940 US5352775A (en) 1991-01-16 1991-08-08 APC gene and nucleic acid probes derived therefrom
PCT/US1992/000376 WO1992013103A1 (en) 1991-01-16 1992-01-16 Inherited and somatic mutations of apc gene in colorectal cancer of humans

Publications (1)

Publication Number Publication Date
GR3036047T3 true GR3036047T3 (en) 2001-09-28

Family

ID=26298271

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010400861T GR3036047T3 (en) 1991-01-16 2001-06-14 Inherited and somatic mutations of apc gene in colorectal cancer of humans.

Country Status (9)

Country Link
EP (1) EP0569527B1 (el)
AT (1) ATE199746T1 (el)
AU (1) AU1366992A (el)
CA (1) CA2100472C (el)
DE (1) DE69231734T2 (el)
DK (1) DK0569527T3 (el)
ES (1) ES2158847T3 (el)
GR (1) GR3036047T3 (el)
WO (1) WO1992013103A1 (el)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0689606A1 (en) * 1993-03-19 1996-01-03 The Johns Hopkins University ANTIBODIES AND ASSAYS FOR DETERMINING MUTATIONS IN THE $i(APC) GENE
US6025127A (en) * 1994-01-14 2000-02-15 The Johns Hopkins University School Of Medicine Nucleic acid mutation detection in histologic tissue
DE4431174A1 (de) * 1994-09-01 1996-03-07 Deutsches Krebsforsch Nachweisverfahren für tumorspezifische mRNA
EP0929661A4 (en) * 1995-11-15 2000-01-12 Univ Utah INNOVATIVE METHOD OF CULTIVATING HUMAN EPITHELIAL CELLS FOR IDENTIFYING THERAPEUTICS AND DIAGNOSTICS AGAINST CANCER
US5670325A (en) * 1996-08-14 1997-09-23 Exact Laboratories, Inc. Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample
US5733732A (en) * 1996-01-03 1998-03-31 University Of Iowa Research Foundation Methods for detecting primary adhalinopathy
US5741650A (en) * 1996-01-30 1998-04-21 Exact Laboratories, Inc. Methods for detecting colon cancer from stool samples
US5952178A (en) 1996-08-14 1999-09-14 Exact Laboratories Methods for disease diagnosis from stool samples
US6146828A (en) * 1996-08-14 2000-11-14 Exact Laboratories, Inc. Methods for detecting differences in RNA expression levels and uses therefor
US6100029A (en) * 1996-08-14 2000-08-08 Exact Laboratories, Inc. Methods for the detection of chromosomal aberrations
US6300077B1 (en) 1996-08-14 2001-10-09 Exact Sciences Corporation Methods for the detection of nucleic acids
US6203993B1 (en) 1996-08-14 2001-03-20 Exact Science Corp. Methods for the detection of nucleic acids
US5928870A (en) * 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6020137A (en) * 1996-08-14 2000-02-01 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US5879890A (en) * 1997-01-31 1999-03-09 The Johns Hopkins University APC mutation associated with familial colorectal cancer in Ashkenazi jews
US6268136B1 (en) 1997-06-16 2001-07-31 Exact Science Corporation Methods for stool sample preparation
US6818404B2 (en) 1997-10-23 2004-11-16 Exact Sciences Corporation Methods for detecting hypermethylated nucleic acid in heterogeneous biological samples
DE19848665A1 (de) * 1998-10-22 2000-04-27 Bayer Ag Ein automatisierbarer Schnelltest zum direkten Nachweis der APC Resistenz Mutation mit spezifischen Primern und Probes
US6280947B1 (en) 1999-08-11 2001-08-28 Exact Sciences Corporation Methods for detecting nucleotide insertion or deletion using primer extension
US6503718B2 (en) 1999-01-10 2003-01-07 Exact Sciences Corporation Methods for detecting mutations using primer extension for detecting disease
CA2366778C (en) 1999-04-09 2008-07-22 Exact Sciences Corporation Methods for detecting nucleic acids indicative of cancer
DE19933237A1 (de) * 1999-07-15 2001-01-18 Max Planck Gesellschaft Verfahren zur Bestimmung der Proliferationsaktivität von Zellen
US6849403B1 (en) 1999-09-08 2005-02-01 Exact Sciences Corporation Apparatus and method for drug screening
WO2001042781A2 (en) 1999-12-07 2001-06-14 Exact Sciences Corporation Supracolonic aerodigestive neoplasm detection
US6919174B1 (en) 1999-12-07 2005-07-19 Exact Sciences Corporation Methods for disease detection
US6271257B1 (en) * 2000-04-17 2001-08-07 Hormos Nutraceutical Oy Ltd. Decreasing the intracellular level of β-catenin by administering hydroxymatairesinol
AU2002211359A1 (en) * 2000-10-04 2002-04-15 Ca*Tx, Inc. Stem cell-based methods for preventing and treating tumor
WO2006047787A2 (en) 2004-10-27 2006-05-04 Exact Sciences Corporation Method for monitoring disease progression or recurrence
US9777314B2 (en) 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples
ES2421354T3 (es) 2006-08-11 2013-08-30 Johns Hopkins University Secuencias consenso codificantes de cánceres de mama y colorrectales humanos
DE102011008050A1 (de) * 2011-01-07 2012-07-12 Universitätsklinikum Schleswig-Holstein Verfahren zur Diagnose der familiären adenomatösen Polyposis (FAP)
MX2013015214A (es) 2011-06-30 2014-03-21 Nanoholdings Llc Metodo y aparato para detectar radiacion infrarroja con ganancia.
US11859246B2 (en) 2013-12-11 2024-01-02 Accuragen Holdings Limited Methods and compositions for enrichment of amplification products
US11286519B2 (en) 2013-12-11 2022-03-29 Accuragen Holdings Limited Methods and compositions for enrichment of amplification products
CN104946737B (zh) 2013-12-11 2019-02-22 安可济控股有限公司 用于检测罕见序列变体的组合物和方法
AU2016334233B2 (en) 2015-10-09 2023-01-05 Accuragen Holdings Limited Methods and compositions for enrichment of amplification products
CN108699505A (zh) 2015-12-03 2018-10-23 安可济控股有限公司 用于形成连接产物的方法和组合物
CA3024630A1 (en) 2016-05-16 2017-11-23 Accuragen Holdings Limited Method of improved sequencing by strand identification
CA3033749C (en) 2016-08-15 2026-03-24 Accuragen Holdings Limited Compositions and methods for detecting rare sequence variants
US11203782B2 (en) 2018-03-29 2021-12-21 Accuragen Holdings Limited Compositions and methods comprising asymmetric barcoding
US12049665B2 (en) 2018-06-12 2024-07-30 Accuragen Holdings Limited Methods and compositions for forming ligation products
CN114539379B (zh) * 2022-03-03 2024-06-07 山东省滨州畜牧兽医研究院 Aqp1突变型基因、蛋白、细胞系及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8719061D0 (en) * 1987-08-12 1987-09-16 Imp Cancer Research Fund Paten Probe
EP0792931A3 (en) * 1988-10-31 1999-05-19 The Regents Of The University Of California Products and methods for controlling the suppression of the neoplastic phenotype

Also Published As

Publication number Publication date
EP0569527A1 (en) 1993-11-18
ES2158847T3 (es) 2001-09-16
AU1366992A (en) 1992-08-27
CA2100472A1 (en) 1992-07-17
DE69231734D1 (de) 2001-04-19
DK0569527T3 (da) 2001-07-16
DE69231734T2 (de) 2001-09-20
WO1992013103A1 (en) 1992-08-06
ATE199746T1 (de) 2001-03-15
EP0569527B1 (en) 2001-03-14
CA2100472C (en) 2009-04-07

Similar Documents

Publication Publication Date Title
GR3036047T3 (en) Inherited and somatic mutations of apc gene in colorectal cancer of humans.
GR3034446T3 (en) Gene mutated in colorectal cancer of humans.
WO2002046477A3 (en) Endogenous retroviruses up-regulated in prostate cancer
CY1111147T1 (el) Διαμεμβρανικο αντιγονο λεκτινης τυπου c εκφραζομενο σε καρκινο στον προστατη ανθρωπου και χρησεις αυτου
FR2657259B1 (el)
AU5299393A (en) Low-power x-ray source with implantable probe for treatment of brain tumors
NO20014560L (no) Quinasoliner og terapautisk anvendelse derav
AU1807401A (en) Compositions and methods for therapy and diagnosis of breast cancer
ZA99693B (en) Compounds for therapy and diagnosis of lung cancer and methods for their use.
HUP0200763A2 (en) Compositions for the treatment and diagnosis of breast cancer and methods for their use
PL346359A1 (en) Compositions and methods for therapy and diagnosis of prostate cancer
PL354093A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
HUP9902068A3 (en) Methods and compositions for the diagnosis and treatment of cancer
PL365244A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
IL142194A0 (en) Gene expressed in prostate cancer
AU6583700A (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
PL350863A1 (en) Compositions and methods for the treatment and diagnosis of breast cancer
DE69927714D1 (de) 19-nor-vitamin d3 derivate mit calciumspiegel erhöhender wirkung
AU2002253899A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU3655097A (en) Brca1 compositions and methods for the diagnosis and treatment of breast cancer
AU4452900A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
BR0308976A (pt) Terapia combinada contra tumores compreendendo derivados de acriloil distamicina substituìda e radioterapia
SADAHIRO et al. A CLINICOPATHOLOGICAL STUDY OF CASES WITH CANCER OF UNKNOWN ORIGIN ANALYSIS OF CELLULAR PROTEINS IN PRIMARY AND METASTATIC CANCEROUS TISSUE
ECSP982800A (es) Metodos para el tratamiento de enfermedades proliferativas